IndraLab

Statements

2-hydroxy-17beta-estradiol inhibits JAK1. 1 / 1

| 1

reach

"In agreement with the above results, when the differentiated ECs were treated with inhibitors to block the JAK-1 and STAT3 pathways, QKI-5 did not activate the EC markers CD31, CD144, eNOS, FLK-1 (VEGFR2), and VEGFA (Supporting Information Fig."

28207177

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

2-hydroxy-17beta-estradiol inhibits JAK1. 1 / 1

INDRA sources:

Databases

Reading